Xconomy National

Archives

by in

Entry	Author	Date	Location
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups	Luke Timmerman	12/22/11	Seattle
Omeros Flunks Pivotal Trials, Dendreon’s Shareholder Hubbub, AVI Biopharma Nabs $30M, & More Seattle-Area Life Sciences News	Luke Timmerman	04/07/11	Seattle
Omeros Fails in Pivotal Trials With Drug for Knee Surgery, Stock Crashes	Luke Timmerman	03/31/11	Seattle
SeaGen Strikes Abbott Deal, Omeros Passes Study, Alnylam Fires Back at Tekmira, & More Seattle-Area Life Sciences News	Luke Timmerman	03/24/11	Seattle
Omeros Combo Drug Passes Cataract Surgery Study	Luke Timmerman	03/23/11	Seattle
The Immunex Alumni, Hood Wins Russ Prize, Williams Grabs Biogen Gig, & More Seattle-Area Life Sciences News	Luke Timmerman	01/06/11	Seattle
Omeros Gets Drugs for Bleeding	Luke Timmerman	01/05/11	Seattle
Adaptive TCR Seeks to Dominate New Industry, Ultrasound on an iPhone, AVI Names CEO, & More Seattle-Area Life Sciences News	Luke Timmerman	12/16/10	Seattle
Life Sciences Discovery Fund Debunks Perceptions with Omeros Deal, Shows State Can Bankroll Companies	Luke Timmerman	12/14/10	Seattle
Dendreon Commercial Guy Leaves, Light Sciences CEO Exits, Amgen Wins FDA OK, & More Seattle-Area Life Sciences News	Luke Timmerman	11/24/10	Seattle
Omeros Adds Discovery Technology	Luke Timmerman	11/23/10	Seattle
Omeros Nabs $25M from Paul Allen and the State, Immune Design Strikes 1st Big Deal, & More Seattle-Area Life Sciences News	Luke Timmerman	10/28/10	Seattle
Omeros Nabs $25M from Paul Allen, State Life Sciences Fund to Pursue Elusive Drug Targets	Luke Timmerman	10/25/10	Seattle
Omeros Addiction Program Wins NIH Grant	Luke Timmerman	10/14/10	Seattle
Omeros Lines Up $40M Financing	Luke Timmerman	07/29/10	Seattle
Ironwood Climbs 3.6 Percent on IPO Debut Day, Shows Investor Interest—Albeit Tepid—in Biotech	Luke Timmerman	02/03/10	Boston
Ironwood Pharma IPO Price Cut Could Be Only Half the Story	Ryan McBride	02/03/10	Boston
Ironwood Gears Up for Biotech’s Biggest IPO in Years, Sending Ripple Effect Through Industry	Luke Timmerman	02/01/10	Boston
M&A Liquidity Up, IPO Market Still Anemic: Fourth-Quarter Data on Venture Exits Is a Mixed Bag	Wade Roush	01/04/10	National
A Brief Year-End Review of Seattle Biotech	Stewart Lyman	12/31/09	Seattle
Bezos Family Gives $10M to Hutch, Bruce Carter Back in the Saddle, Dendreon Deadline Set, & More Seattle-Area Life Sciences News	Luke Timmerman	11/25/09	Seattle
Ironwood Files to Go Public, Seeks to Raise as Much as $172.5M	Luke Timmerman	11/20/09	Boston
Omeros Banks on First FDA Filing Next Year, Plans to “Unlock” Inaccessible Drug Targets	Luke Timmerman	11/19/09	Seattle
ZymoGenetics Rival Emerges, Omeros IPO Casts Shadow, Microsoft’s HealthVault Seeks Users, & More Seattle Area Life Sciences News	Luke Timmerman	10/29/09	Seattle
Omeros, Worst Performing IPO of 2009, Casts Shadow Over Other Aspiring Biotechs	Luke Timmerman	10/27/09	Seattle
Top 10 Northwest Venture Deals of the Third Quarter—and VC Color Commentary	Gregory T. Huang	10/20/09	Seattle
Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News	Luke Timmerman	10/15/09	Seattle
Amazon Invests in Engine Yard, PopCap Raises $22.5M, Omeros Goes Public, & More Seattle-Area Deals News	Gregory T. Huang	10/14/09	Seattle
Omeros, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day	Luke Timmerman	10/08/09	Seattle
Omeros Raises $68.2M in Washington’s First IPO in Two Years	Luke Timmerman	10/08/09	Seattle
Page 1 of 2	next page »